Pulmonary and hematological alterations in idiopathic ulcerative colitis

Indian Journal of Gastroenterology

Volumn 22, Issue 5, 2003, Pages 176-179

  Sethy, Pradeepta Kumar ^a   Dutta, Usha ^a   Aggrawal, Ashutosh N ^a   Das, Reena ^a   Gulati, Madhu ^a   Sinha, Saroj Kant ^a   Singh, Kartar ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Coagulation abnormalities; Extraintestinal manifestations; Pulmonary function test

Indexed keywords

CARBON MONOXIDE; FIBRINOGEN;

ARTHRITIS; ARTICLE; BLOOD CLOTTING; BUDD CHIARI SYNDROME; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EVALUATION; EYE; EYE DISEASE; HEMATOLOGIC DISEASE; HUMAN; IDIOPATHIC DISEASE; LIVER BIOPSY; LIVER FUNCTION TEST; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG FUNCTION; LUNG FUNCTION TEST; MUSCULOSKELETAL SYSTEM; OBSTRUCTIVE AIRWAY DISEASE; PREVALENCE; PROSPECTIVE STUDY; RADIODIAGNOSIS; SACROILIAC JOINT; SACROILIITIS; SKIN; STATISTICAL SIGNIFICANCE; THORAX; THROMBOCYTE COUNT; THROMBOCYTOSIS; ULCERATIVE COLITIS;

ADULT; ARTHRITIS; COLITIS, ULCERATIVE; FEMALE; HEMATOLOGIC DISEASES; HUMANS; LUNG DISEASES; MALE; PREVALENCE; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; SACROILIAC JOINT;

EID: 0345686618     PISSN: 02548860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Allan RN. Extraintestinal manifestations of inflammatory bowel disease. Clin Gastroenterol 1983;12:617-30.
2. Kochhar R, Mehta SK, Nagi B. Extraintestinal manifestation of idiopathic ulcerative colitis. Indian J Gastroenterol 1991;10:88-9.
3. Danzi JT. Extraintestinal manifestations of idiopathic inflammatory bowel disease. Arch Intern Med 1988;148:297-302.
4. Camus P, Piard F, Asheroft. The lung in inflammatory bowel disease. Medicine 1993;72:151-83.
5. Greenstein AJ, Janowitz HD, Sachar DB. The extraintestinal complications of Crohn's disease and ulcerative colitis: A study of 700 patients. Medicine 1976;55:401-12.
6. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Br Med J 1955;1:1041-8.
7. Linden SV. Ankylosing spondylitis. In: Kelly WN, Harris ED, Ruddy S, Sledge CB. Eds. Textbook of Rheumatology, 5th ed. Philadelphia: WB Saunders. 1997: p. 969-82.
8. Tandon BN, Mathur AK, Mohapatra LN, Tandon HD. A study of the prevalence and clinical pattern of non-specific ulcerative colitis in northern India. Gut 1965;6:448-53.
9. Kapur S, Agarwal SK. Ulcerative colitis in northern India. Indian J Gastroenterol 1986;5:247-8.
10. Chutani HK, Nigam S, Sama SK, Dhandi PC, Gupta PS. Ulcerative colitis in tropics. Br Med J 1967;4:204-7.
11. Gadekar NG. Ulcerative colitis: Incidence and diagnosis. Indian J Radiol 1962;16:151-66.
12. Marvisi M, Borrello PD, Brianti M. Changes in the carbon monoxide diffusing capacity of the lung in ulcerative colitis. Eur Respir J 2000;16:965.
13. Eade OE, Smith CL, Alexander JR, Whorwell PJ. Pulmonary function in patients with inflammatory bowel disease. Am J Gastroenterol 1980;73:154-6.
14. Sharma MP, Kar P. Pulmonary functions in ulcerative colitis. J Assoc Physicians India 1985;33:613-4.
15. Higenbottam T, Cochrane GM, Clark TJH. Bronchial disease in ulcerative colitis. Thorax 1980;35:581-5.
16. Tzanakis N, Bouros D, Samiou M. Lung function in patients with inflammatory bowel disease. Respir Med 1998;92:516-22.
17. Storch I, Sachar D, Katz S. Pulmonary manifestations of inflammatory bowel diseases. Inflamm Bowel Dis 2003;9:104-15.
18. Olosson R, Danielson, Jarnerot G. Prevalence of primary sclerosing cholangitis in patients of ulcerative colitis. Gastroenterology 1991;100:1319-23.
19. Sartor RB. Pathogenic and clinical relevance of cytokines in inflammatory bowel disease. Immunology 1991;10:465-71.
20. de Jong E, Porte RJ, Knot EA. Disturbed fibrinolysis in patients with inflammatory disease. A study in blood plasma, colon mucosa, and faeces. Gut. 1989;30:188-94.
21. van Bodergraven AA, Tuynman HA, Schrool M, Bartels PCM. Fibrinolytic split products, fibrinolysis and factor XIII activity in inflammatory bowel disease. Scand J Gastroenterol 1995;30:580-5.
22. Linskens RK, Bodegraven AA, Schoorl M, Bartels PCM. Predicting value of inflammatory and coagulation parameters in course of severe ulcerative colitis. Dig Dig Sci 2001;46:644-8.
23. Conlan MG, Haire WD, Burnett DA. Prothrombotic abnormalities in inflammatory bowel disease. Dig Dig Sci 1993;43:1501-4.
24. Heneghan MA, Cleary B, Murray M, O'Gorman TA, McCarthy CF. Activated protein C resistance, thrombophilia, and inflammatory bowel disease. Dig Dis Sci 1998;43:1356-61.
25. Knot EAR, Ten Cate JW, Leeksma OCH, Tyagat GN, Vreeken J. No evidence for prothombotic state in stable chronic inflammatory bowel disease. J Clin Pathol 1983;36:1387-90.
26. Lam A, Borda II, Inwood MJ. Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology 1975;68:245-51.
27. Jewell DP. Ulcerative colitis. In: Sleisenger MH, Fordtran JS. Eds. Gastrointestinal and Liver Disease, 6th ed. Philadelphia: WB Saunders. 1993: p. 1735-61.
28. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut 1964;5:1-22.
29. Praderio L, Dagna L, Longhi P, Rubin G, Sabbadini MG. Budd-Chiari syndrome in a patient with ulcerative colitis: association with anticardiolipin antibodies. J Clin Gastroenterol 2000;30:203-4.
30. Mistilis SP. Pericholangitis and ulcerative colitis: pathology, etiology, and pathogenesis. Ann Intern Med 1965;63:17-26.
31. Ghosh P, Kochhar R, Nagi B, Mehta SK. Primary sclerosing cholangitis. J Assoc Physicians India 1987;36:538-40.